# HEALIXAI GDPR ARTICLE 35 DATA PROTECTION IMPACT ASSESSMENT (DPIA) & TIA
**Document Version:** 2026.11-GDPR-UKGDPR  
**Assessment Date:** 2026-11-20  
**Approving Officer:** Ricardo Hamilton, MD (CEO & Data Protection / Clinical Safety Officer)  

---

## 1. Systematic Description of Processing (Art. 35(7)(a))
HealixAI provides real-time clinical voice/chat navigation, patient-authorized SMART on FHIR R4 medical record synthesis, clinic pre-visit intake, and clinician decision support. Because processing involves **Special Category Health Data (Art. 9)** and real-time AI inference, HealixAI maintains this standing Article 35 DPIA.

## 2. Necessity, Proportionality & Data Minimization (Art. 35(7)(b))
- **Strict Read-Only EHR Scopes:** SMART on FHIR patient connections use read-only scopes (`Patient.read`, `Condition.read`, `MedicationRequest.read`, `Observation.read`) secured via OAuth 2.0 PKCE S256.
- **Stateless Voice Transport:** WebRTC voice audio streams over DTLS-SRTP and is processed ephemerally in memory without storing raw audio recordings on translation nodes.
- **Zero Ad/Behavioral Tracking:** HealixAI loads zero third-party advertising or analytics cookies.
- **12-Month Dormancy Auto-Purge:** Dormant accounts are automatically purged at 365 days (following a 30-day advance notice at month 11).

## 3. Risk Assessment & Mitigations to Rights and Freedoms (Art. 35(7)(c)-(d))
| Identified Risk | Inherent Severity | Technical & Clinical Mitigation Implemented | Residual Risk |
| :--- | :--- | :--- | :--- |
| **Hallucinated or Unsafe Clinical Output** | High | Deterministic sub-150ms Red-Flag Emergency Gatekeeper, PyHealth Drug-Drug Interaction engine, Beers Criteria 2023 checks, and NIH PubMed / UK NICE citation grounding. | **Low** |
| **Solely Automated Clinical Decisions (Art. 22)** | High | HealixAI acts strictly as an informational & clinician-support companion; clinical exemptions, prescriptions, and care orders require human clinician review/co-signature. | **Low** |
| **Unauthorized Access or Credential Leakage** | High | AES-256 Cloud KMS encryption at rest, TLS 1.3 in transit, Firebase Admin `verifyIdToken` server gates, and SSRF-hardened FHIR endpoints. | **Low** |
| **Incomplete Deletion Across Distributed Stores** | Medium | Unified `DELETE /api/privacy/gdpr` cascade purges Firestore profile, clinical vault, saved items, WhatsApp state, BigQuery transcripts, and Firebase Auth, issuing a zero-PII SHA-256 receipt. | **Low** |
| **US Cross-Border Transfer Exposure (Schrems II)** | Medium | Encrypted in transit (TLS 1.3 / DTLS-SRTP) and at rest (AES-256), zero LLM retention, EU SCCs (2021/914) + UK IDTA with all Tier-1 subprocessors. | **Low** |

## 4. Supervisory & Physician Review Conclusion
Residual privacy and clinical safety risks are assessed as **Low and Acceptable**. This DPIA is reviewed semi-annually and upon any material change to foundation model architecture or subprocessor topology.
